Understand any stock in simple English
Enter a ticker to learn what the company does and how it makes money.
Japan Tobacco sells cigarettes and other tobacco products around the world, and also runs a large prescription drug business and a frozen-food business.
Japan Tobacco is one of the world's big cigarette makers. It sells brands like Winston, Camel, Mevius, and LD in more than 100 countries, and it also sells heated-tobacco sticks that heat tobacco instead of burning it. Its home market is Japan, where it has long dominated cigarette sales, but most of its smokers now live outside Japan. It also has two smaller but real businesses: a prescription-drug arm and a frozen-food arm, which together give it income that has nothing to do with smoking.

The money engine is simple. Smokers buy a pack, and a big chunk of the price goes to governments as tobacco tax. JT keeps the rest, minus the cost of making and shipping the pack. Cigarettes are cheap to produce and highly addictive, so the business throws off piles of cash. That cash pays a hefty dividend and funds share buybacks, and it also lets JT buy rivals. The company has spent billions over the years buying brands and businesses abroad, including overseas tobacco operations and, more recently, a big stake in a heated-tobacco maker. The catch is that smoking is shrinking almost everywhere, as governments ban advertising, restrict where people can smoke, and raise taxes. JT's answer is to charge more per pack and sell alternatives like heated tobacco, and to slowly grow the drug and food arms. The company has also been buying back its own shares, including a plan to repurchase roughly 2.6% of its shares, which shrinks the share count and lifts the value of each share that remains.
Japan's story in tobacco starts with the government itself. In the late 1800s it formed a bureau to run a monopoly on selling domestic leaf tobacco, so the state, not private merchants, controlled the trade. That small bureau eventually became the Japan Tobacco and Salt Public Corporation, the country's sole tobacco producer, a public body that made cigarettes for the whole nation.
By the 1980s, outside pressure to open Japan's market to foreign tobacco firms, plus the limits of running a business as a government corporation, pushed the country to let go. So the monopoly was abolished and Japan Tobacco Inc. was born, taking over the old public corporation's business and assets β just as foreign manufacturers got the right to sell in Japan too.
The government began selling its JT shares to the public, and the stock listed on Japan's big exchanges. It did not go well: lottery winners mostly passed on the shares, and the stock opened about a quarter below its offer price. The market, in other words, was not excited.
Then came the move that changed JT's scale. It bought the non-U.S. tobacco business of RJR Nabisco, picking up global brands like Winston and Camel, and set up an international arm headquartered in Geneva. International sales volume jumped more than ninefold in a single year β the company was suddenly a player far beyond Japan.
JT went shopping again in the U.K., buying the whole of Gallaher Group and adding brands such as LD and Benson & Hedges. The integration roughly doubled the company overnight and made international tobacco its main profit driver. The once-domestic monopoly was now a global cigarette business.
One of JT's best-known global brands, Mild Seven, got a new name: MEVIUS. A simple rename, but a signal that the company was thinking about its brands on a world stage.
As concerns about smoking grew, JT launched Ploom TECH heated tobacco in Japan, its first real entry into reduced-risk products. The same year it also bought the non-U.S. tobacco business of Natural American Spirit, adding another international brand to its portfolio.
JT pulled its domestic and international tobacco operations into a single unit called One Team, moving the tobacco headquarters functions to Geneva. The goal was simple: compete and earn better as one business instead of two halves.
JT then bought Vector Group, the fourth-largest cigarette company in the U.S., for about $2.4 billion. Even with the world turning against smoking, JT doubled down on cigarettes, expecting most of its revenue to still come from them a decade later.
A Russian presidential decree placed JT's Russian manufacturing subsidiaries under temporary management, later expanding to seven entities. JT shares, which had just hit an all-time high, fell nearly 20% to the daily limit the next day, wiping about Β₯3 trillion off its value. Russia was roughly a tenth of revenue and about a quarter of operating profit β losing control of it put the company's high-dividend outlook in doubt.
There is a darker side too. Japan Tobacco is majority-owned by the Japanese government, and its products kill people when used as intended. It is also exposed to currency swings, since it earns money in many countries but reports in yen. For investors, JT is a cash machine with a slowly eroding base: a cheap, high-dividend stock whose long-term question is whether it can replace cigarettes fast enough before they fade.
Saved answer Β· last researched 8 Nov 2026
Japan Tobacco sells 63 out of every 100 cigarettes smoked in Japan
In its home market, Japan Tobacco controls 63% of cigarette sales by retail volume. That grip matters because Japan is where the company earns much of its money, and it means foreign rivals fight for a small slice of the shelf. The rest of the world is a tougher contest, where the company holds roughly a fifth of the market outside China. Source: Euromonitor, data from 2025